Hospicio Divino Salvador, Inc Medicare Approved Location: Road 2, Km 40, Plaza Jardines, Vega Baja, Puerto Rico 00694 Phone: (787) 855-0411 |
News Archive
Having received clearance under Section 510(k) from the U.S. Food and Drug Administration, Spacelabs Healthcare is adding the qube patient monitor to its Art of Monitoring portfolio. Inspired by the revolutionary style of the company's XPREZZON patient monitor, qube breaks with tradition to offer a fresh, new perspective in compact monitoring.
Researchers at Mayo Clinic have reported a causal link between senescent cells — cells that accumulate with age and contribute to frailty and disease — and osteoarthritis in mice.
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced it had raised gross proceeds of approximately $10.6 million via the sale of approximately 4.5 million shares of common stock at a weighted average price of $2.34 per share.
› Verified 5 days ago